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Abstract
: Traditional eye medicine (TEM) is frequently used to treatBackground
microbial keratitis (MK) in many parts of Africa. Few reports have
suggested that this is associated with a worse outcome. We undertook this
large prospective study to determine how TEM use impacts presentation
and outcome of MK and to explore reasons why people use TEM for
treatment in Uganda.
 
: In a mixed method prospective cohort study, we enrolledMethods
patients presenting with MK at the two main eye units in Southern Uganda
between December 2016 and March 2018 and collected information on
history, TEM use, microbiology and 3-month outcomes. We conducted
qualitative interviews with patients, carers traditional healers on reasons
why people use TEM. Outcome measures included presenting vision and at
3-months, comparing TEM Users versus Non-Users. A thematic coding
framework was deployed to explore reasons for use of TEM.
 
: Out of 313 participants enrolled, 188 reported TEM use. TEMResults
Users had a delayed presentation; median presenting time 18 days versus
14 days, p= 0.005; had larger ulcers 5.6 mm versus 4.3 mm p=0.0005; a
worse presenting visual acuity median logarithm of the minimum angle of
resolution (Log MAR) 1.5 versus 0.6, p=0.005; and, a worse visual acuity at
3 months median Log MAR 0.6 versus 0.2, p=0.010. In a multivariable
logistic regression model, distance from the eye hospital  and delayed
presentation were associated with TEM use. Reasons for TEM use
included lack of confidence in conventional medicine, health system
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 included lack of confidence in conventional medicine, health system
breakdown, poverty, fear of the eye hospital, cultural belief in TEM,
influence from traditional healers, personal circumstances and ignorance.
 
: TEM users had poorer clinical presentation and outcomes.Conclusion
Capacity building of the primary health centres to improve access to eye
care and community behavioural change initiatives against TEM use should
be encouraged.
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Introduction
Microbial keratitis (MK) frequently leads to sight-loss from dense 
corneal scarring, or even loss of the eye, especially when the 
infection is severe and/or appropriate treatment is delayed1. MK 
has been described as a “silent epidemic”, which leads to sub-
stantial morbidity, related to blindness and other consequences 
such as pain and stigma2. It is the leading cause of unilateral 
blindness after cataract in tropical regions and is responsible 
for about 2 million cases of monocular blindness per year3.
In Low and Middle-Income Countries (LMIC), use of 
Traditional Eye Medicine (TEM) for treatment of many eye 
conditions is a common practise4–6. In the few reported studies, 
TEM has been found to lead to complications such as corneal 
scarring and delayed presentation of patients to hospital resulting 
in poor outcomes7,8.
Literature on TEM use for MK is scanty. However, among the 
three papers from Sub-Saharan Africa (SSA), TEM use among 
patients with MK was reported to be associated with a severe 
presentation. These studies did not report clinical outcomes9–11. 
In addition, since most of the TEM involves plant products such 
as fresh leaves, it could have a major role in the pathogenesis of 
fungal keratitis, which has been associated with  injuries involv-
ing vegetative matter12,13. Our experience in Uganda is that TEM 
is widely used to treat a number of eye conditions including 
MK. However, the drivers of this practice are not well understood.
The aim of this study therefore was to determine how TEM 
use impacts presentation and outcome of MK and to explore 
reasons why people use TEM for treatment of MK in Uganda.
Methods
Ethical statement
This study adhered to the Declaration of Helsinki. It was 
approved by the London School of Hygiene & Tropical Medi-
cine Ethics Committee (Ref 10647), Mbarara University Research 
Ethics Committee (Ref 10/04-16) and Uganda National Coun-
cil for Science and Technology (Ref HS-2303). Written informed 
consent in Runyankore, the local language, was obtained 
before enrolment. If the patient was unable to read, the 
information was read to them, and they were asked to indi-
cate their consent by application of their thumbprint. The col-
lected source data is stored in a secure database at Mbarara 
University of Science and Technology. An anonymised digital 
version was also uploaded in a secure server. The data will be 
kept for 7 years according to institutional policy.
Participants
Due to the cultural complexity of TEM usage, we used a mixed 
methods approach. We prospectively enrolled patients with 
MK that consecutively presented to two tertiary eye hospi-
tals in South-Western Uganda from December 2016 to March 
2018. The case definition of MK was the presence of a corneal 
epithelial defect (of at least 1mm diameter) with an underly-
ing stromal infiltrate, associated with signs of inflammation 
(conjunctival hyperaemia, anterior chamber inflammatory cells, 
+/- hypopyon). We excluded those not willing to participate, those 
not willing to return for follow-up, pregnant women, lactating 
mothers, those aged below 18 years.
Quantitative assessment
We documented basic demographic information and ophthal-
mic history using ophthalmic nurses as part of the routine hos-
pital work up. This included treatment received including prior 
use of TEM. For those who reported use of TEM, a detailed 
structured history was taken on what they had applied, source 
of the medicines, cost, how it was prepared, duration of use and 
any complications experienced. A detailed description of the 
cases evaluation has been previously presented. In summary, 
after measurement of the presenting visual acuity (Logarithm 
of Minimum Angle of Resolution), cases underwent a detailed 
clinical examination on a slit lamp using a structured proto-
col, including eyelid assessment, corneal ulcer features, anterior 
chamber (flare, cells, hypopyon shape and size) and perforation 
status. Corneal scrapes were collected for microscopy, culture 
(blood agar, chocolate agar, potato dextrose agar) and molecular 
diagnosis. HIV, Diabetes counselling and testing were offered, 
as per the Uganda Ministry of Health HIV testing protocol. 
Cases were treated according to the hospital protocol, which 
usually involved a brief admission for the first few days. The 
study follow-up assessment schedule was days 2, 7, 21 and 
90, to determine outcome. Patients were asked to return to the 
eye hospital for these reviews where their follow up data was 
collected as before. Additional assessments were conducted 
as clinically indicated. The primary outcome measure was 
final best corrected vision at 3 months. See extended data14 for 
questionnaire used.
Qualitative assessment
All interviews and discussion groups were conducted by AA. 
They were audio recorded and summarised. Additional contex-
tual information provided such as patient emotions, environment 
and any other aspect the interviewer found noteworthy.
Firstly, at presentation, patients who reported to have used TEM 
were asked if they would be willing to discuss their experi-
ences. For such patients, an interviewer would return later that 
evening or the next day when the patient was more relaxed. 
Interviews were conducted in the local language by a social 
            Amendments from Version 1
In this revised version, we have addressed all the reviewer 
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status was not significant in the multivariate analysis.
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had better presenting acuity than non TEM users, this has been 
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scientist either at the hospital bedside (when quiet) or in the hos-
pital compound depending on the patient’s preference. The focus 
of the interview was to explore reasons why they had used TEM.
Secondly, we conducted informal group discussions (IGDs) with 
a sample of the MK patients involved in the study and relatives 
of people with MK on the practise and reasons why people use 
TEM. This was an opportunistic approach to allow flexible data 
collection. For example, a patient might present escorted by 
many family members and friends (common in this setting), 
such a group would then be invited to discuss issues around 
TEM. Such a naturally composed group was to result in a more 
relaxed discussion than a group of people who did not know each 
other who are brought together solely for the discussion.
Finally, we conducted in-depth interviews with traditional heal-
ers to learn about what they would usually do for people pre-
senting with a problem like MK and why people go to them for 
treatment. Healers were identified from a traditional healers’ 
registry at the local council headquarters. A random sample of 
15 traditional healers were contacted through their coordinator. 
Those willing to share their knowledge and practise in treating 
eye problems particularly MK were visited and interviewed at 
their home or shrine.
For all the groups, topic guides were developed using available 
literature and experiences of the local ophthalmologists treat-
ing patients with MK (see extended data14). They included 
local understanding of MK, causes, treatment and experiences 
of using TEM. The guides were piloted among a few patients 
and modified accordingly. The final version was approved 
by all the authors who included senior social scientists (AA) 
and a professor (JS). In this report, our focus is on reasons why 
people use/do not use TEM. These were reviewed by one of the 
authors. They were then piloted among MK patients and revised 
accordingly. All interviews lasted about 30–45 minutes.
Analysis
Quantitative data were analysed using STATA v14. We com-
pared demographic data, baseline clinical presentation and 
final vision outcomes at 3-months of patients who reported to 
have used TEM versus those who had not. Appropriate tests of 
significance (chi2 for categorical data and Wilcoxon rank sum for 
continuous data) were employed. Multivariable logistic regression 
analysis was used to identify factors associated with TEM use. 
Initially, univariable regression was performed to generate 
crude odds ratios (OR). Variables with a p-value less than 0.1 
were introduced in the multivariable model. A back stepwise 
approach was then used, until only the variables with a p-value 
of less than 0.05 were retained. Adjusted OR were reported for 
the final model. Summary tables of proportions were constructed 
to describe the source, cost, complications and duration of use 
of TM.
For the qualitative data, all interviews were recorded with an 
audio recorder (Olympus WS-853 Digital Stereo Voice Recorder) 
and transcribed into summaries. These were independently 
reviewed several times by two of the authors (SA and JS). A 
coding framework was developed, and data were then manually 
coded. Emerging themes around reasons why people used/did 
not use TEM are presented. Specific conversation response clips 
from the respondents that supported the generated themes were 
extracted from the audio recordings and used as illustrative 
statements.
Results
We enrolled 313 people with MK, of whom 188 (60%) reported 
TEM use (“TEM Users”) and 125 said they did not use TEM 
(“TEM Non-Users”). The demographic characteristics of both 
groups are shown in Table 1 (see underlying data14). There were 
some differences between TEM Users and Non-Users. TEM 
Users lived further from the eye unit, were more frequently 
farmers, were less likely to be married and had progressed less in 
formal education.
The clinical characteristics of both groups are shown in 
Table 2. There was evidence that the condition of TEM Users 
was worse than TEM Non-Users at presentation. The TEM Users 
presented later, had larger corneal ulcers (both infiltrate and 
epithelial defect), more frequent hypopyons and poorer vision.
We modelled factors associated with TEM use (Table 3). After 
adjusting for potential confounders, distance from the eye 
hospital and delayed presentation were associated with TEM 
use. Whereas, there was less TEM use among those who were 
married, had a history of trauma and a high education level.
At 3-months, 260 patients completed their follow-up. There was 
no systematic baseline difference between patients who were seen 
at 3-months and those that were not. The final LogMAR visual 
acuity was worse among TEM Users, median 0.6 (IQR 0-2.5), 
compared to TEM Non-Users, 0.2 (IQR 0-1.5), p=0.010.
Among the 188 patients who reported TEM use, 137 (73%) 
used TEM after they had been to a government health facil-
ity (secondary TEM use). TEM was mostly made from fresh 
leaves [154, (82%)]; the commonest preparation method was to 
freshly squeeze them [145, (77%)]. Most patients obtained TEM 
either from their home garden (40%) or from a neighbour (54%), 
only 5 patients (3%) obtained TEM from a traditional healer. 
TEM was generally free, 169 (90%) reported not to have spent 
any money to obtain it.
The qualitative study involved a total of 38 participants: 11 
traditional healers, 21 MK patients who had used TEM and 6 
MK patients who had not used TEM. The baseline character-
istics of these individuals are presented in Table 4. Overall, it 
was a mix of male and female, young and old, not educated 
and highly educated. In addition, three informal group discus-
sions (IGDs) were conducted, each with around 15 partici-
pants (these were naturally composed groups of patients who 
had used or not used TEM, relatives and friends).
The major factors coming out as the reasons for using TEM 
included lack of consumer confidence in conventional medi-
cine, health system breakdown, poverty, fear, cultural belief in 
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Table 2. Baseline clinical characteristics of participants (n=313), comparing traditional eye medicine (TEM) users to 
non-users.
Variable
TEM Users (188) TEM Non-Users (125)
Median (IQR) (Total range) Median (IQR) (Total range) P value
Presentation time in days 18 (12–35) (1–274) 14 (5–32) (0–370) 0.005
Infiltrate size in mm* 5.6 (3.8–8.1) (0.5–11) 4.3 (2.4–6.8) (0.6–12) 0.0005
Epithelial defect size in mm* 4.2 (2.5–11) (0–14) 3.6 (2.2–5.1) (0–11) 0.0105
Presenting Vision (Log MAR) 1.5 (0.3–2.5) (0–4) 0.6 (0.2–2.5) (0–4) 0.005
Count (%) count (%) P value
Visual Acuity > 6/18 50 (27) 52 (42) 0.011
6/18 – 6/60 24 (13) 18 (14)
< 6/60 113 (60) 55 (44)
Eye discharge Yes 107 (57) 60 (48) 0.122
History of Trauma Yes 42 (22) 49 (39) 0.001
Presence of lid swelling Yes 85 (46) 45 (36) 0.097
Slough Ɨ None 31 (17) 30 (24) 0.246
Flat 77 (41) 47 (38)
Raised 78 (42) 46 (37)
Infiltrate colour White 77 (44) 71 (63) 0.005
Cream 76 (43) 30 (27)
Other 23 (13) 11 (10)
Table 1. Baseline demographics characteristics of participants (n=313), comparing traditional eye medicine (TEM) 
users to non-users.
Variable
TEM Users (188) TEM Non-Users (125)
Median (IQR) (Total range) Median (IQR) (Total range) P value
Age 48 (34–60) (18–87) 45 (35–60) (18–96) 0.651
Distance to eye hospital (km) 87 (59–132) (1.5–378) 67 (42–121) (0.2–316) 0.003
Distance to nearest Health Centre in (km) 3 (1–5) (0–45) 2 (1–4) (0–35) 0.528
Count (%) count (%) P value
Gender Male 101 (54) 73 (58) 0.415
Occupation Farmer 140 (75) 80 (64) 0.047
Non-farmer 48 (25) 45 (34)
Education None 59 (31) 25 (20) 0.016
Primary Level 98 (52) 64 (51)
Secondary Level 23 (12) 22 (18)
Tertiary Level 8 (5) 14 (11)
Marital status Unmarried* 66 (35) 29 (23) 0.025
Married 122 (65) 96 (77)
Household SES Ɨ Poor 51 (28) 34 (29) 0.520
Middle 116 (64) 72 (60)
Upper 13 (7) 13 (11)
SES: Socioeconomic status.
*Unmarried included-single, divorced, widowed. Ɨ This was relative self-reported economic status compared to the neighbours.
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Table 3. Univariable and multivariable logistic regression for factors associated with traditional eye medicine use (n=313).
Variable Univariable Analysis Multivariable Analysis
Crude OR (95% CI) p-value Adjusted OR (95% CI) p-value
Age in years 1.002 (0.988-1.016) 0.699
Distance to Eye hospital (for every km) 1.005 (1.001-1.0090 0.009 1.004 (1.001-1.008) 0.035
Distance to the nearest Health Centre (for every km) 1.028 (0.971-1.089) 0.332
Sex (Being male) 0.82 (0.52-1.30) 0.415
Occupation (Being a farmer) 1.64 (1.01-2.68) 0.048
Married 0.55 (0.33-0.93) 0.026 0.54 (0.31-0.95) 0.035
Education level
None 1 0.016 1 0.059
Primary 0.64 (0.36-1.14) 0.71 (0.38-1.30)
Secondary 0.44 (0.20-0.93) 0.44 (0.20-1.00)
Tertiary 0.24 (0.09-0.65) 0.28 (0.09-0.83)
Household economic status
Low 1 0.526
Middle 1.07 (0.63-1.81)
Upper 0.66 (0.27-1.61)
Presentation time
0–3 days 1 <0.001 1 0.002
4–7 days 2.17 (0.72-6.53) 1.50 (0.46-4.83)
8–14 days 6.03 (2.10-17.3) 4.76 (1.55-14.6)
15–30 days 5.77 (2.03-16.4) 4.37 (1.44-13.2)
>30 days 4.89 (1.75-13.6) 3.74 (1.27-11.1)
History of trauma 0.44 (0.26-0.72) 0.001 0.43 (0.25-0.74) 0.003
Variable
TEM Users (188) TEM Non-Users (125)
Median (IQR) (Total range) Median (IQR) (Total range) P value
Hypopyon Yes 66 (35) 28 (22) 0.014
Perforated at admission Yes 29 (15) 16 (13) 0.517
Microbiology Unknown 38 (23) 27 (25) 0.089
Bacteria 10 (6) 10 (10)
Fungus 108 (67) 60 (55)
Mixed 6 (4) 11 (10)
Log MAR: Logarithm of the minimum angle of resolution.
*These were calculated as the geometrical means using the MUTT protocol15. The upper limits exceeded normal corneal diameter for some 
lesions, which extended up to the sclera. Ɨ Raised slough was when the corneal infiltrate profile was raised, flat slough was when the profile 
was flat while no slough is when there was no debris noted. The difference in presenting vision and infiltrate sizes remained significant even 
after adjusting for delayed presentation.
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Table 4. Baseline characteristics of people who participated in the in-depth interviews, including 
traditional healers and patients with microbial keratitis (both traditional eye medicine (TEM) users 
and non-users).
Participant Age Sex Marital status Occupation Household size Education Religion
Traditional Healers (n=11)
1 70 Male Divorced Farmer 1 None Christian
2 56 Female Married Farmer 4 None Christian
3 52 Female Widowed Farmer 3 None Christian
4 76 Female Married Farmer 8 Primary Christian
5 78 Female Married Farmer 5 - -
6 53 Female Widowed Farmer 2 - Christian
7 72 Female Widowed TBA 4 Primary Christian
8 82 Male Divorced Farmer 8 None Christian
9 59 Male Married Carpenter 18 Secondary Christian
10 69 Female Married TBA 6 Primary Christian
11 60 Female Widowed TBA 5 Primary Christian
TEM Users (n=21)
1 42 Male Married Farmer 7 Primary Christian
2 46 Male Married Charcoal maker 8 Primary Christian
3 26 Male Married Mechanic 4 Primary Christian
4 53 Female Married Farmer 5 Primary Christian
5 38 Female Married Farmer 3 Primary Christian
6 26 Male Single Graduate 5 Tertiary Christian
7 18 Female Single Farmer 6 Secondary Christian
8 39 Male Married Farmer 5 None Muslim
9 85 Female Widowed Farmer 18 None Christian
10 60 Female Married Business 5 None Christian
11 72 Female Married Farmer 8 None Christian
12 29 Male Married Teacher 3 Tertiary Christian
13 60 Male Married Farmer 6 Primary Muslim
14 39 Female Married Farmer 5 Primary Christian
15 54 Male Married Guard 4 Primary Christian
16 58 Female Married Farmer 4 Primary Christian
17 30 Female Divorced Farmer 4 Primary Christian
18 81 Male Married Farmer 9 None Christian
19 81 Male Married Farmer 5 Primary Christian
20 69 Male Married Farmer 17 Primary Christian
21 20 Male Single Shop keeper 20 Primary Muslim
TEM Non-Users (n=6)
1 56 Male Married Teacher 6 Tertiary Christian
2 25 Male Married Bike rider 6 Primary Christian
3 39 Male Married Accountant 1 Tertiary Christian
4 30 Female Single Hairdresser 1 Primary Christian
5 20 Male Single Farmer 10 Secondary Christian
6 19 Female Single Student 4 Tertiary Muslim
TBA: Traditional Birth Attendant;
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TEM, Role of Traditional Healers, personal circumstances and 
Ignorance.
Lack of confidence in conventional medicine
While some participants reported visiting health centres for 
treatment, many talked of resorting to TEM with the persist-
ence in pain after use of conventional medicine. A 26-year male 
mechanic said “At first, I got some relief when I put the eye 
drop, but later, it pained me severely and I was advised to use 
herbs. Having seen no great improvement, I started using herbs.” 
A participant in an IGD told us “We are using western medi-
cine to no avail. You can use western medicine for a week or a 
month but don’t get healed.” A 75-year male traditional healer 
reported that “many people with eye problems come to me 
because some even fail to get cured from Mbarara hospital and 
are referred to me. I then put my traditional eye medicine like 
twice and they gain or enjoy life again.” These statements sup-
ported the observation above that the majority (73%) of the TEM 
users had applied it after they had visited a health facility.
Lack of service in health facilities
Inadequate care including lack of medicines, rude health work-
ers, unskilled health workers and poorly equipped health 
facilities, especially government owned ones, were reported as 
major drivers to use of TEM by a majority of patients. “There 
are no experts or doctors experienced in treating eye diseases 
in Health Centres within our vicinities. When you find a 
doctor at a Health Centre, they say that they don’t know such an 
eye disease you are suffering from” (a 28-year unemployed man). 
The majority of primary health facilities do not have trained 
primary eye care workers. Eye patients are reviewed by 
general health workers who may have limited experience with 
managing ophthalmic condition. Eye care workers are nurses 
who have received an ophthalmic certificate course in examina-
tion and management of common eye conditions. In addition, 
as an 81-year-old farmer put it “Health facilities within our 
areas don’t have eye medicine, examination machines and they 
are also unwelcoming to a person who has gone there. One just 
looks at the eye, prescribes the medicine and start treating the 
illness. Or, you hear medicine has been brought but when you 
go there the next day, you are told there is no medicine.” 
Poverty as a barrier to access care
With subsistence farmers constituting the major part of the pop-
ulation, poverty was reported as a key barrier to accessing eye 
care, encouraging people to opt for TEM. This was expressed 
as being unable to afford transport to eye hospitals and treat-
ment. In an IGD1, one respondent told us “Those of us who are 
able to afford treatment are very few you can count them; many 
people who have the same problem have turned blind because 
they cannot afford treatment.” Another person added “It’s a result 
of poverty! Many people in the village have no money. Even 
sometimes you don’t have money in the pocket, so you pick the 
herb and apply it to the sick eye. You get to come here at the 
facility when you can’t count the types of herbs you have tried 
just because of poverty.” Compared to going to hospital and the 
costs involved, TEM was a far cheaper option: the majority of 
the patients had obtained it from within their homesteads and had 
not spent any money on it.
Fear of the eye hospital
Most people lived far from the eye hospital and fear of travel-
ling long distances, which was reported as a constraint. “One 
can be having money but chooses not come to the hospital 
fearing how he will reach. Not all people are poor, but one just 
wonders where he is to pass and continue to Mbarara eye 
hospital. There are reluctant for example one says he won’t be 
able to reach the place he has never gone to” (an 81-year old male 
farmer from a distant village). We found that most of the 
patients travelled l distances (about 90 km) to reach the only 
referral eye hospitals in Mbarara town. Another form of fear 
was of what treatment would be offered; some people thought 
that this would make them go blind. For example, a participant 
in IGD2 told us “What stops them from going to the hospital is 
that one is told they are going to operate your eye and after that 
it means that it is damaged completely you will never see again. 
That is the reason many people fear coming to the hospital, 
they say when you are operated the eye ends up getting dam-
aged. They say when you reach in the hospital and get operated, 
it doesn’t get well” 
Cultural understanding of MK and its treatment
Use of TEM in general is viewed as an acceptable practice 
and as part of culture in the community. It was revealed by 
several participants that MK is culturally understood as a disease 
to be treated locally. Almost all participants talked of receiving 
advice to use TEM from fellow community members who 
attest that it cured them. An 81-year old female farmer told us 
“People in communities don’t know that MK as an eye disease 
is treated in hospitals or that there are hospitals that can treat 
it. People say it is cured by traditional eye medicine.” Another 
42-year old farmer said “The old people we live with know 
those medicines and they testify that they cured them. Therefore, 
they encourage one who is suffering from an eye disease to keep 
using them saying he too will get well.” Most of the people came 
from rural settings where there is a strong sense of community.
Belief in TEM
From the experience of previous TEM users and personal 
experience of use, it was not surprising that almost all par-
ticipants who had used TEM believed it was effective. They 
attributed their failure to heal to their body makeup. “The old 
people believe and know that traditional eye medicine cures eye 
diseases. There are people, they identified for me who used the 
same medicine and got well. Even themselves, they told me that 
they used it and got cured” (a 42-year male farmer). “The 
person who gave me traditional eye medicine told me she too 
suffered from the same disease and got healed by the same 
herbs” (a 60-year old butter maker). On being asked why it had 
not worked for them, a 53-year old female farmer responded 
“those who don’t heal I think the condition of the eye might 
have needed medical attention from doctors as genetically 
people are different. There is one who heals by traditional 
eye medicine and another who doesn’t and is only treated by 
modern medicine from hospitals.” 
Role of traditional healers
With the belief and acceptance that use of TEM is within 
their culture, many had confidence in traditional healers. The 
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traditional healers themselves also had a strong confidence in 
their medicine and reported remarkable cure rates. One 56-year 
old traditional healer said: “They go to the hospitals and 
come back to me when they have failed to heal with modern 
medicine. I give them traditional eye medicine and they get healed, 
none that I have treated or given my medicine has failed to get 
well” Another 75-year old male healer reported “There are 
many people I have treated; none I gave my medicine has 
ever complained that it failed to heal her or him. Whoever I 
meet just praises God and prays for me to be blessed. I treat 
people with faith in God.” 
Personal circumstances
Desperation due to the pain of the condition and the view of 
TEM as a form of first aid was mentioned as a prompt to use 
traditional medicine. This was mostly reported among patients 
who used TEM before presenting to health facilities. Participants 
explained that with the pain, one can use anything recommended 
to him or her to the extent of accepting TEM containing needle 
prick blood from another person without being afraid of con-
tracting HIV. A 42-year male farmer told us “This disease is so 
painful. No one should suffer from it because, with pain you 
can use anything given to you. You are not mindful of HIV, you 
only want the pain gone”. A 85-year female farmer wondered, 
“Can anyone who has been found in pain and recommended an 
herb fail to use it? Pain can make you do anything”.
Lack of awareness to the dangers of TEM
Interestingly, most participants did not think using TEM could 
be dangerous. “Traditional eye medicine doesn’t damage the 
eye, it just rinses or cleanses it” (a 46-year old male charcoal 
burner). “There are no risks of using traditional eye medicine 
because when one fails to get healed, she or he goes somewhere 
else or to hospitals” (an 85-year female farmer). In addition, 
some thought it was better than conventional medicine and did 
not have any side effects like most conventional medicines. 
A 59-year old traditional healer said, “Our herbal medicine 
is fresh not preserved.” 
Discussion
This study investigated the extent of TEM use by people with 
microbial keratitis, and how this impacts their clinical presenta-
tion and outcome. We went on to explore more deeply the spe-
cific practices and the reasons and beliefs behind using TEM. 
The use of TEM in Southern Uganda in the treatment of MK is 
common (60%), and more frequent than that previously reported 
from Malawi (34%) and Tanzania (25%)9,10. Importantly, we 
found that people who used TEM presented later with a more 
severe clinical picture and they ended up with worse final 
visual acuity outcomes at 3-months, compared to those who 
had not used TEM.
Our findings are similar to previous reports from Malawi, which 
found that patients who had used TEM presented later than 
those who had not used TEM9,16. The previous studies, how-
ever, did not examine final outcomes, after the infection had 
been treated. MK is a disease where prompt treatment is critical 
if one is to improve the likelihood of a good outcome. We know 
from prior literature that once an infection is advanced, treat-
ment does relatively little to change its course17. The clear 
conclusion from earlier studies from South Asia and East 
Africa is that effective treatment of MK should be started as 
early as possible to save the eye and achieve the best possible 
outcomes18,19.
In this study we combined both quantitative modelling 
approaches and complementary qualitative approaches to inves-
tigate not only “what” but also “why” people use TEM. In the 
explanatory multivariable model, increasing distance to the eye 
hospital, lower education level, an onset not linked to trauma and 
not being married were associated with TEM use. These were 
explored further in the informal group discussions (IGDs). 
These discussions the major reported reasons for using TEM 
were around consumer confidence in the health system, access, 
poverty and cultural influence.
Importantly, we found that most people who used TEM did so 
after first visiting a government health facility. This is consistent 
with the IGDs, in which people felt that conventional medicine 
was not helping, leading them to resort to alternative approaches. 
This conclusion could be a result of inappropriate treatment. 
However, even with appropriate treatment, the clinical response 
can be slow, especially for fungal keratitis. Patients need to 
be properly counselled to manage expectations. Another impor-
tant aspect is good pain management on top of the anti-microbial 
treatment. Patients reported that desperation due to pain made 
them more likely to try many options to find relief. This initial 
early contact point with the formal health system represents 
an opportunity to improve the diagnosis and treatment of 
people with MK, through providing enhanced training, diagnostic 
tools and medication in the primary care setting.
Lack of appropriate ophthalmic medicines is a major challenge. 
For example, the best current evidence indicates that topical 
natamycin is the treatment of choice for filamentous fungal 
keratitis20. However, this is currently not readily available in 
the main ophthalmic units Uganda or elsewhere in SSA. It is 
certainly not available in more isolated locations. Therefore, 
patients with a fungal MK will not access effective treatment 
until they arrive in a major eye unit. Natamycin was added 
to the WHO Essential Medicines List in 2018, which will 
hopefully result in greater availability soon.
Limited access to eye care was a major driver of TEM use. This 
was evident in the regression modelling, with increasing TEM 
use with increasing distance to the eye hospitals. The majority of 
TEM users came from districts relatively far away where no eye 
care facilities were situated. This was a strong and frequently 
articulated theme in the interviews and discussions. Multiple 
people commented on the lack of eye health services in the 
nearby health facilities, the long distances to the eye hospi-
tal and poverty is a major barrier to access (because of the high 
transport and other direct costs). Several people also highlighted 
that government health centres near to them have no eye spe-
cialists or treatment and do not treat eye conditions. Pharmacies 
simply sell available eye drop medication, with no examination; 
frequently these are steroid and antibiotic combinations which may 
result in more harm than good in fungal keratitis. Unfortunately, 
Uganda still grapples with a severe shortage of human resources 
and infrastructure for eye health21.
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Although the regression model did not demonstrate a relation-
ship between economic status and TEM Use, during the IGDs 
poverty was reported to be a major driver for using TEM. In the 
model, there were only a handful of people in the upper eco-
nomic status which may have obscured this relationship. The 
majority of the patients were subsistence farmers and therefore 
not able to readily afford the cost of medicines and transpor-
tation. In contrast, TEM could be accessed closer to home at 
almost no cost. Most of the patients used got the TEM from their 
nearby gardens or from the neighbour and applied it freshly 
squeezed into the eye. People who are married may have 
access to greater household financial resources, possibly 
explaining why being married was associated with less TEM use.
We found that TEM use was linked to strong cultural beliefs 
and this seemed related to the level of education. In the model, 
people with no or little education were more likely to use 
TEM. It was worrying that people did not perceive TEM use as 
potentially dangerous. This was also reinforced by messages 
from traditional healers and older members of the commu-
nity who carry a high level of respect. Public health orientated 
messaging and health education need to particularly focus on and 
work with these groups. There is some evidence from Malawi 
and Nigeria, where ophthalmologists worked with traditional 
healers to lower the use of TEM, that changes are possible7,16. 
Although, in our context, only 3% of TEM users consulted a tra-
ditional healer, their place in society cannot be underestimated 
and it would be in our best interest to bring them on board.
Strengths/limitations
The use of a mixed methods approach provided a more inform-
ative data on reasons for using TEM for MK in Uganda. To the 
best of our knowledge, this was the first study in SSA that 
looked at 3-month outcomes of people who had used TEM 
for treatment of MK. Although a sensitive topic, it was noted 
that participants and traditional healers were willing to talk 
about their TEM experiences. We did not have any evidence that 
people withheld information. The large numbers were enough 
to have a well powered study to explore factors associated 
with TEM use. Inclusion of children would have provided a 
more overall understanding of this topic, however, this was 
not practical in out setting.
Conclusion
TEM use is an important factor in the presentation and out-
come of MK in Uganda, leading to delayed presentation to hos-
pital, a poor presentation and a worse outcome. Cultural beliefs, 
access to the health system (due to poverty and long distances) 
and inherent challenges in the primary health centres (lack of 
knowledge, medicines, equipment and supplies) are major 
drivers of TEM use. Sensitisation of the people and capacity 
building in the primary health centres will be a step in the right 
direction to mitigate these effects.
Data availability
Underlying data
Havard dataverse: Traditional Eye Medicine use in Microbial 
Keratitis in Uganda. https://doi.org/10.7910/DVN/5GOPKZ14.
This project contains the following underlying data:
•    tem_data_descriptive_5May2019.tab (quantitative underly-
ing data)
•    tem_coding_framework_May2019.tab (codes of qualitative 
data responses)
Extended data
Havard dataverse: “Topic guides for exploring Traditional 
Eye Medicine Use for treatment of Microbial Keratitis in 
Uganda.docx”, Traditional Eye Medicine use in Microbial 
Keratitis in Uganda, https://doi.org/10.7910/DVN/5GOPKZ14.
This project contains the following underlying data
•    Topic guides for exploring Traditional Eye Medicine 
Use for treatment of Microbial Keratitis in Uganda.docx 
(Topic guides that were used to probe respondents to 
talk about their understanding, opinions and experiences 
of using Traditional Eye Medicine)
•    Quantitative questionnaire on use of Traditional Eye 
Medicine.docx (A of a quantitative questionnaire that was 
used to collect information from all the patients with MK 
on their history of use of Traditional Eye Medicine)
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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 This is a useful addition to the mounting evidence that improving the early treatment of microbial keratitis
should be a priority for prevention of blindness programmes.
The authors conclude that TEM is more likely to be used if patients have less access to effective
eye care facilities. Although poverty was cited by many participants as a driver for TEM use, it was
not significant in the multivariate analysis. This may be explained by the paucity of higher SES
patients in both groups. I think it is likely that poverty does contribute to TEM use, alongside the
other factors.
 
Although the text of the results section states that TEM users had worse presenting acuity than non
TEM users, the data in Table 2 appears to contradict this, and I suspect there may be an error in
the table.
 
This study confirms the finding of previous authors who noted that TEM use is associated with a
greater risk of hypopyon. The underlying assumption of this article is that all patients had microbial
keratitis prior to TEM use. However, it is possible that some may have had self-limiting, or minor
conditions, such as a corneal abrasion or conjunctivitis. The introduction of unsterile preparations
on to a compromised ocular surface may have led to   development of microbial keratitis.de novo
 
An unexpected finding is that TEM use in this population was usually independent of traditional
healers. I have always assumed that TEM use is partly driven by a desire for answers that western
medicine is not good at providing, particularly "Why has this happened to me?". This study would
seem to indicate that the main motivation for most patients was a simple desire for faster and
greater improvement in their symptoms.
 
A less surprising finding is that outcomes were significantly worse for patients using TEM. Previous
studies have not been able to obtain outcome data, as it can be difficult for these patients to return
for review. It is valuable to have clear evidence that TEM use is harmful.
 
One significant weakness in the study is the exclusion of children. In Tanzania we found that 50%
of TEM users were aged 11 or younger. I suspect that the findings would be similar in children and
adults, but the authors should acknowledge this weakness in the discussion.
 
The ready availability of TEM in people's homes and gardens means that campaigns to reduce the
use of TEM are unlikely to be successful. Prevention of blindness programmes would be better to
focus on improving the delivery of eyecare, and raising the quality of the care delivered.
Anecdotally, I can report that TEM use was widespread in a poor part of rural Tanzania, but almost
non-existent in the relatively developed Central Province of Kenya. My experience would appear to
support the authors' conclusion that improving rural eye care will lead to a decline in the harms
caused by TEM.
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If applicable, is the statistical analysis and its interpretation appropriate?
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 If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Vitreoretinal surgery, public health ophthalmology in developing countries
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
Author Response 02 Sep 2019
, London School of Hygiene & Tropical Medicine, London, UKSIMON ARUNGA
 The authors conclude that TEM is more likely to be used if patients have less access toComment:
effective eye care facilities. Although poverty was cited by many participants as a driver for TEM
use, it was not significant in the multivariate analysis. This may be explained by the paucity of
higher SES patients in both groups. I think it is likely that poverty does contribute to TEM use,
alongside the other factors.
Response: We agree with the reviewer that poverty does contribute to TEM use and was
indeed reported by many participants. In the multivariable model, there were only a
handful of people in the upper economic status which may have obscured this
relationship. We have added this comment in lines 339-341. Also to note is that
SES/Access/poverty are all on a similar/same causal path and do not function
independently of each other.
Although the text of the results section states that TEM users had worse presentingComment: 
acuity than non TEM users, the data in Table 2 appears to contradict this, and I suspect there may
be an error in the table.
Response: We thank the reviewer for spotting this. We noticed that the data had been
accidentally interchanged. It has been corrected in table 2.
: This study confirms the finding of previous authors who noted that TEM use isComment
associated with a greater risk of hypopyon. The underlying assumption of this article is that all
patients had microbial keratitis prior to TEM use. However, it is possible that some may have had
self-limiting, or minor conditions, such as a corneal abrasion or conjunctivitis. The introduction of
unsterile preparations on to a compromised ocular surface may have led to de novo development
of microbial keratitis.
Response: We agree with the reviewer and feel the same way. However, there was no way
of objectively ascertaining this fact. We intend to explore this in our future studies.
: An unexpected finding is that TEM use in this population was usually independent ofComment
traditional healers. I have always assumed that TEM use is partly driven by a desire for answers
that western medicine is not good at providing, particularly "Why has this happened to me?". This
study would seem to indicate that the main motivation for most patients was a simple desire for
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 study would seem to indicate that the main motivation for most patients was a simple desire for
faster and greater improvement in their symptoms.
Response: Indeed, this was surprising. Only 3% of the participants visited a traditional
healer to obtain TEM. From our further exploration of this in the qualitative studies, our
impression is that  since the“everyone in the community is a traditional healer”
knowledge of the herbs is common among the community members. However, this does
not negate the role of the healers since they are strong advocates for TEM use.
: A less surprising finding is that outcomes were significantly worse for patients usingComment
TEM. Previous studies have not been able to obtain outcome data, as it can be difficult for these
patients to return for review. It is valuable to have clear evidence that TEM use is harmful.
Response: We thank the reviewer for acknowledging this new contribution.
: One significant weakness in the study is the exclusion of children. In Tanzania weComment
found that 50% of TEM users were aged 11 or younger. I suspect that the findings would be similar
in children and adults, but the authors should acknowledge this weakness in the discussion.
Response: We thank the author for this comment. Although we provided care for children
who presented with Microbial Keratitis, the design of our study enrolled only adults due to
pragmatic reasons such as being able to test people for HIV, subjecting children under
general anaesthesia for corneal scrapping and ethical approvals for a vulnerable group. In
addition, we found out during the pilot phase that microbial keratitis was not very
common among children in our setting, accounting for only about 3% of all microbial
keratitis cases. However, this point has been acknowledged in the limitation. lines
364-365.
: The ready availability of TEM in people's homes and gardens means that campaigns toComment
reduce the use of TEM are unlikely to be successful. Prevention of blindness programmes would
be better to focus on improving the delivery of eyecare, and raising the quality of the care
delivered. Anecdotally, I can report that TEM use was widespread in a poor part of rural Tanzania,
but almost non-existent in the relatively developed Central Province of Kenya. My experience
would appear to support the authors' conclusion that improving rural eye care will lead to a decline
in the harms caused by TEM.
 Response: We thank the reviewer for this comment.
 n/aCompeting Interests:
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 1.  
2.  
3.  
4.  
5.  
This report gives an account of the "mystery" surrounding the traditional eye medicine usage in the
treatment of microbial keratitis. The practice is rampant in some of the developing and underdeveloped
countries and the more we know and understand this practice better we can get at influencing people to
make a distance from them. Social, cultural, economical and emotional factors - all seem to be
responsible for continued presence of this unwanted practice. This reviewer appreciates the efforts of the
authors in putting up this paper together which is very well written. Following are minor comments that
may help make the paper even better:
Abstract: Results begins with digits which in good writing should be avoided and replaced with
words.
 
Methods: Clinical examination and microbiological methods are not described at all. A description
would allow better understanding of how the data was collected.
 
Analysis, Page 4, results, last but one line: The word farmer is spelt wrongly with one "r" missing.
 
There is no data on what type of organisms were involved in the microbial keratitis in the two study
groups. If microbiology was done, as is claimed in methods, there should be results of the same.
Similarly, how were the patients treated in the control group that did not receive traditional eye
medicine? These are important determinants of the outcome in the two groups that have been
compared. My comments of "partly satisfied" are related to these issues.
 
Discussion: Para 2, line 6: “...if one is improve the likelihood of a good outcome.” This sentence is
incorrect with a missing word "to".
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Partly
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: I am a clinical microbiologist in an academic tertiary care eye centre with over 25
years experience in diagnosing and researching microbial keratitis cases in India. I have published
extensively and written book chapters in the area of ocular infections including microbial keratitis. My
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 extensively and written book chapters in the area of ocular infections including microbial keratitis. My
research areas include fungal keratitis, Acanthamoeba keratitis, antibiotic susceptibility, infection control,
molecular diagnosis of eye infections, infectious endophthalmitis etc.
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard, however I have significant
reservations, as outlined above.
Author Response 02 Sep 2019
, London School of Hygiene & Tropical Medicine, London, UKSIMON ARUNGA
: Abstract: Results begins with digits which in good writing should be avoided andComment
replaced with words.
Response: We thank the reviewer for spotting this. We have revised this sentence to read
“Out of 313 participants enrolled, 188 reported TEM use”.
 Methods: Clinical examination and microbiological methods are not described at all. AComment:
description would allow better understanding of how the data was collected.
Response: We thank the reviewer for this comment. The detailed assessment of the
patients has been described in a different report (under review), however, we have
revised the manuscript and summarised patient assessment. Line 48-55.
 Analysis, Page 4, results, last but one line: The word farmer is spelt wrongly with oneComment:
"r" missing.
Response: We thank the author for spotting this. It has been corrected. Line 115.
 There is no data on what type of organisms were involved in the microbial keratitis inComment:
the two study groups. If microbiology was done, as is claimed in methods, there should be results
of the same. Similarly, how were the patients treated in the control group that did not receive
traditional eye medicine? These are important determinants of the outcome in the two groups that
have been compared. My comments of "partly satisfied" are related to these issues.
Response: We would like to draw the attention of the reviewer to the last section of table 2
which summarises the types of organisms in the two groups. Although the proportion of
fungal keratitis was more common among the people who had used TEM, the evidence of
this difference was weak. We agree with the reviewer that treatment for people with
keratitis should consider the history of use of TEM since that could influence the
organisms involved, especially in the absence of a good microbiology support. However,
treatment of the participants in our study was dependant on the microbiological findings.
 Discussion: Para 2, line 6: “...if one is improve the likelihood of a good outcome.” ThisComment:
sentence is incorrect with a missing word "to"
 Response: We thank the author for spotting this. It has been corrected. Line 296.
 n/aCompeting Interests:
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